Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
about
Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.Thrombotic thrombocytopenic purpura and its diagnosis.The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.Treatment of thrombotic thrombocytopenic purpura.Thrombotic microangiopathies: an update.Normal levels of ADAMTS13 and factor H are present in the pharmaceutically licensed plasma for transfusion (Octaplas) and in the universally applicable plasma (Uniplas) in development.Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura.Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies.ST segment elevation myocardial infarction as a presenting feature of thrombotic thrombocytopenic purpura.The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research.Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasmaMyocardial Infarction as an Early Presentation in Thrombotic Thrombocytopenic Purpura: A Rare Case Series.Thrombotic thrombocytopenic purpura
P2860
Q33365640-1350EF23-ADED-4C41-BE29-9BDFC41C6E50Q33366296-7EB46638-6012-4C0C-A363-3FC7171D52A4Q33366493-97E57EAC-894B-448C-94B6-EC6E4CD87B5AQ33370956-0C5E1DD1-7D57-43A0-8898-17A259EA2B0EQ33374370-1C1BE3C0-E049-4F17-91EE-73679747C076Q33374478-E7B08BE4-3079-476B-A04A-4DAD8AA8B7C5Q33395145-209262F1-213A-46F5-8B53-38A29432D577Q33401314-1EE9FCC7-1E5B-4A9D-9FD7-4FCFB1066BE5Q33401432-8582BDF4-A1FD-46C8-B916-1959A570CBD4Q33409105-A49E3715-A95F-46EF-9D9C-A24D8ECF5F66Q33411009-0D6A0748-4C7E-4E86-BA47-52992B220869Q37062415-977D586E-1460-4A7A-B89C-157F2C867285Q54998968-70002CF2-BE75-4646-BA7E-40B1F5BB1CB9Q57591162-A7EA4A74-5FE3-4AF2-B052-B61BAEE3C842
P2860
Plasma therapy in thrombotic thrombocytopenic purpura: review of the literature and the Bern experience in a subgroup of patients with severe acquired ADAMTS-13 deficiency.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@ast
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@en
type
label
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@ast
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@en
prefLabel
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@ast
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@en
P2093
P50
P1476
Plasma therapy in thrombotic t ...... acquired ADAMTS-13 deficiency.
@en
P2093
Behrouz Mansouri Taleghani
Jan-Dirk Studt
Stefano Fontana
P356
10.1053/J.SEMINHEMATOL.2003.10.010
P577
2004-01-01T00:00:00Z